Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ongoing and Intensified Molecular Testing Education Needed Globally

Publish date:: October 22, 2019

Key clinical point: Continuous education around molecular testing should be intensified to ensure that patients receive optimal therapy.

Major finding: A third of respondents reported being unaware of updated guidelines on molecular testing for lung cancer.

Study details: A survey of 2,537 specialists.

Disclosures: The IASLC survey was funded by AstraZeneca. Dr. Smeltzer reported receiving research support from the Bristol Myers Squibb Foundation.

Citation:

Smeltzer M et al. WCLC 2019, Abstract PR01.05.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Lung Cancer

Two different radiation boost strategies reduce local failures in NSCLC,

Rechallenge ‘reasonable’ for some with small-cell lung cancer,

Black patients with ES-SCLC get less chemo but have better survival,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Reduced cancer mortality with Medicaid expansion,